1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
Clinical trial NCT02283190 · COMPLETED
Trial details
- NCT number
- NCT02283190
- Sponsor
- Ashkan Emadi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.